Effect of membrane incorporation of 1-palmitoylcarnitine on surface charge of human erythrocytes.
C Gruver, A J Pappano
Index: J. Mol. Cell. Cardiol. 25 , 1275-1284, (1993)
Full Text: HTML
Abstract
1-Palmitoylcarnitine (1-PC) reduced the electrophoretic mobility of human erythrocytes bathed in low ionic strength solution. Unlike divalent cations which appear to reduce electrophoretic mobility by screening surface negative charge, cationic 1-PC does so by being incorporated into the plasma membrane. Incorporation of 1-PC was assessed directly by measurement of the partition coefficients which are 1.18 x 10(5) and 1.38 x 10(5) in sarcoplasmic reticulum vesicles and erythrocyte ghosts, respectively. The hydrophobic nature of the amphiphile interaction with erythrocyte membrane was also evident as an antihemolytic effect at 1-PC concentrations that also reduced electrophoretic mobility. Moreover, the potency and efficacy of acylcarnitines to reduce electrophoretic mobility increased as the acyl chain length increased. 1-PC also reduced the electrophoretic mobility of guinea-pig ventricular myocytes in low ionic strength solution. Estimation of the zeta potential yielded positive shifts of 4 mV in myocytes and 5 mV on erythrocytes at 1 microM 1-PC. These voltage shifts are essentially the same as those reported for activation and inactivation of sodium and calcium currents in myocytes. Therefore, the surface charge effect of 1-PC depends upon membrane incorporation and underlies the electrophysiological actions of the amphiphile including arrhythmias.
Related Compounds
Related Articles:
1987-12-15
[Cancer Res. 47 , 6537-6542, (1987)]
1992-12-01
[Br. J. Pharmacol. 107 , 1192-1197, (1992)]
1994-01-01
[Cardiovasc. Res. 28 , 129-134, (1994)]
1997-10-01
[Basic Res. Cardiol. 92 , 320-330, (1997)]
1998-01-01
[Am. J. Nephrol. 18 , 355-358, (1998)]